This was detected largely among global FOXA1-binding sites and inhibited FOXA1 binding at specific loci, suggesting that alterations in Tet 2-mediated pathway may have a significant implication for treating advanced PCa [37]. This evidence concerns the gene FOXA1 and posterior cortical atrophy.